You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

CLINICAL TRIALS PROFILE FOR MONOPRIL-HCT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MONOPRIL-HCT

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00776334 ↗	Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions	Completed	Ranbaxy Laboratories Limited	N/A	2002-10-01	The objective of this study is to compare the relative bioavailability of fosinopril sodium 40 mg tablets (Ranbaxy Laboratories Limited, Lot No. 1238312) with that of Monopril® in healthy adult subjects under fasting conditions.
NCT00776672 ↗	Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions	Completed	Ranbaxy Laboratories Limited	N/A	2002-10-01	The objective of this study is to compare the relative bioavailability of fosinopril sodium 40 mg tablets (Ranbaxy Laboratories Limited, Lot No. 1238312) with that of Monopril® in healthy adult subjects under non-fasting conditions.
NCT00777972 ↗	Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions	Completed	Ranbaxy Laboratories Limited	N/A	2003-03-01	The objective of this study was to compare the relative bioavailability of Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets by Ranbaxy Laboratories Limited with that of Monopril ®.-HCT 20-12.5 mg tablets by Bristol-Meyers Squibb following a single oral dose (1 x 20-12.5 mg tablet) in healthy adult subjects under fasting conditions
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MONOPRIL-HCT

Condition Name

Chart
Table

Condition Name for MONOPRIL-HCT
Intervention	Trials
Healthy	4
Hypertension	1
Hypotension on Induction	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MONOPRIL-HCT
Intervention	Trials
Hypotension	1
Disease	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MONOPRIL-HCT

Trials by Country

Map
Table

Trials by Country for MONOPRIL-HCT
Location	Trials
United States	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MONOPRIL-HCT
Location	Trials
Missouri	4
Nebraska	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MONOPRIL-HCT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MONOPRIL-HCT
Clinical Trial Phase	Trials
Phase 4	1
N/A	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MONOPRIL-HCT
Clinical Trial Phase	Trials
Completed	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MONOPRIL-HCT

Sponsor Name

Chart
Table

Sponsor Name for MONOPRIL-HCT
Sponsor	Trials
Ranbaxy Laboratories Limited	4
University of Nebraska	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MONOPRIL-HCT
Sponsor	Trials
Industry	4
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.